Enterprises
Xiuzheng Pharmaceutical Group
Updated: Jan 30, 2019
chinadaily.com.cn
Print
Share - WeChat
Xiuzheng Pharmaceutical Group (修正集团), established in 1995, is a modernized large-scale private pharmaceutical enterprise with total assets of 17 billion yuan ($2.53 billion) and an operating revenue of 63.6 billion yuan by the end of 2016.
Its businesses include scientific research, production and marketing of patent medicine, and chemical and biological pharmacy, along with medicine chain operation and standard cultivation of Chinese medicinal materials.
Having achieved rapid development, the group ranked No 53 in the list of "China's Top 500 Private Enterprises" in 2016.
MOST POPULAR
- 1 China to give visa-free treatment to another 9 countries
- 2 China fully opens manufacturing sector to foreign investors in landmark opening up move
- 3 China's import expo attracts record-breaking participating countries, exhibitors
- 4 China's door opening even wider to foreign visitors, businesses
- 5 China revises rules to ease foreign strategic investment in listed firms
Editors' Picks
Infographic:
China's public holidays for 2025
Infographic:
Basic facts of APEC
Infographic:
Wrapping up the 7th CIIE: Data recap
